research Randomized Clinical Trial of Low-Dose Oral Minoxidil for the Treatment of Female Pattern Hair Loss: 0.25 mg Versus 1 mg
1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.
Search
for
Sort by
Research
120-150 / 1000+ results
research Safety and Tolerability of Low-Dose Oral Minoxidil in Adolescents: A Retrospective Review
The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.
research Low Dose Oral Minoxidil and the Conundrum of Cardiovascular Complications
Low dose oral minoxidil can help with hair growth but may cause serious heart problems, so doctors need to be careful.
research Low Dose Oral Minoxidil as Monotherapy in Patients With Hair Loss
Low dose oral minoxidil can help with hair loss when used alone.
research Low-Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System With a Focus on Pericardial Effusions
Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.
research Low-Dose Oral Minoxidil Improves Hair Length and Global Hair Density in Short Anagen Syndrome
Low-dose minoxidil helps hair grow longer and thicker in people with short anagen syndrome.
research Dermatologists' Knowledge, Attitude, and Practice Pattern Toward Low-Dose Oral Minoxidil in Hair Loss in Saudi Arabia
Saudi dermatologists' understanding and use of low-dose oral Minoxidil for hair loss may not be fully represented due to a small survey sample and language barriers.
research Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Low-dose oral minoxidil is safe for treating hair loss, especially in women, with side effects stopping after use ends.
research Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.
research Minoxidil: Topical or Oral
research Effectiveness and Safety of Low-Dose Oral Minoxidil in Male Androgenetic Alopecia
Low-dose oral minoxidil effectively improves male hair loss with mild side effects.
research Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.
research Safety of Low-Dose Oral Minoxidil Treatment for Hair Loss: A Systematic Review and Pooled Analysis of Individual Patient Data
Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.
research Low-Dose Oral Minoxidil for Treating Alopecia: A 3-Year North American Retrospective Case Series
Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.
research Low-Dose Oral Minoxidil for Treatment of Androgenetic Alopecia and Telogen Effluvium in a Pediatric Population: A Descriptive Study
Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.
research Permanent Chemotherapy-Induced Alopecia After Hematopoietic Stem Cell Transplantation Treated With Low-Dose Oral Minoxidil
The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.
research There Is a Positive Dose-Dependent Association Between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings From a Systematic Review With Meta-Regression Analyses
Low-dose oral minoxidil effectively promotes hair growth but has associated risks.
research Gender Differences in Adverse Effects and Dosing Practices of Low-Dose Oral Minoxidil for Androgenetic Alopecia: A Retrospective Analysis of 310 Patients
Start low-dose minoxidil gradually, especially for women, to reduce side effects.
research Comparative Analysis of Low-Dose Oral Minoxidil with Spironolactone Versus Finasteride or Dutasteride in Female Androgenetic Alopecia Management
Both treatment combinations improved hair growth similarly and were safe.
research Low Dose Oral Minoxidil in COVID-19-Associated Telogen Effluvium: A Retrospective Analysis of 69 Patients
Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.
research Assessing Low-Dose Oral Minoxidil Efficacy in Androgenetic Alopecia: A Comparative Study of AGA and AGA Unmasked by Telogen Effluvium
Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
research Side Effects’ Frequency Assessment of Low Dose Oral Minoxidil in Male Androgenetic Alopecia Patients
Low dose oral minoxidil is safe for treating hair loss in men.
research Response to 'Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Clinically Significant Blood-Pressure Changes: A Retrospective Study'
research Low-Dose Oral Minoxidil for Treatment of Androgenetic Alopecia: Gender Differences in Blood Pressure and Hypotension-Related Adverse Effects
research Low-Dose Oral Minoxidil for Androgenetic Alopecia Is Not Associated With Clinically Significant Blood-Pressure Changes: A Retrospective Study
Taking a small dose of the hair growth medicine minoxidil by mouth does not really change your blood pressure.
research Low-Dose Oral Minoxidil for Alopecia: A Single-Center Retrospective Review
Low-dose oral minoxidil may be effective for hair loss treatment.
research Safety and Tolerability of Low Dose Oral Minoxidil Monotherapy in Female Pattern Hair Loss: A Retrospective Review With Longitudinal Ambulatory Blood Pressure Monitoring
Low dose oral minoxidil is generally safe and can improve hair loss in women, with some experiencing side effects and minimal blood pressure changes.
research Persistent Chemotherapy-Induced Alopecia Treated With Low Dose Oral Minoxidil: A Multicenter Retrospective Case Series of 15 Patients
Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.